Robbi A. Kupfer

Robbi A. Kupfer

Auto-generated profile, based on publicly available information

Robbi A. Kupfer

Department of Otolaryngology–Head and Neck Surgery University of Michigan Ann Arbor Michigan USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2021 in OTO Open
Verified
Journal Article
Open access
PDF file
ANAndrew J. Neevel
Andrew J. Neevel
ASAri D. Schuman
Ari D. Schuman
RMRobert J. Morrison
Robert J. Morrison
NHNorman D. Hogikyan
Norman D. Hogikyan
RKRobbi A. Kupfer
Robbi A. Kupfer
Objectives: In‐office serial intralesional steroid injections (SILSIs) have become a commonly used treatment for subglottic stenosis. We characterized the impact of SILSIs on the time between operating room visits and incidence of glucocorticoid systemic side effects.Study Design: Retrospective case series.Setting: Academic tertiary care center.Methods: All patients with subglottic stenosis receiving SILSIs at 1 institution from 2016 to 2020 were included. Surgery‐free interval was compared using paired t tests. Side effect incidence was calculated with Kaplan‐Meier methodology for visualization.Results: Nineteen patients and 207 procedures were included. The majority of patients were White (95%) and female (95%) and had idiopathic subglottic stenosis (53%). Mean surgery‐free interval for all patients was 8.7 months (95% CI, 5.6‐11.8) before initiating SILSIs. Of 11 patients with calculable surgery‐free interval, 10 experienced improvement, with a mean surgery‐free interval increase of 4.6 months (95% CI, 2.4‐6.7). Seven patients have not required surgery since initiation of SILSIs, with a mean follow‐up time of 28 months (95% CI, 25‐31). Noncutaneous systemic side effects occurred at a mean 3.2 months (95% CI, 2.4‐4.0) from first injection and included Cushing’s syndrome, increased intraocular pressure, central serous chorioretinopathy, and new insulin requirement in the setting of diabetes.Conclusions: Ninety‐one percent of patients who initiated SILSIs and had a subsequent return to the operating room experienced a mean 4.6‐month increase in surgery‐free interval. Systemic side effects of glucocorticoids occurred in 32% of patients after initiating SILSIs. This should be considered in preprocedure counseling and side effect monitoring during treatment.

1 March 2020 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
RHRebecca C. Hoesli
Rebecca C. Hoesli
ATAaron L. Thatcher
Aaron L. Thatcher
NHNorman D. Hogikyan
Norman D. Hogikyan
RKRobbi A. Kupfer
Robbi A. Kupfer
Recurrent respiratory papillomatosis (RRP) is a disease characterized by benign papillomatous lesions of the upper airway that often cause debilitating dysphonia and may result in airway obstruction. Because of its recurrent nature, multiple surgical excisions are required to manage RRP, resulting in patient morbidity and high health care use.1,2 Intralesional injections of the antiviral medication cidofovir have been used in an attempt to decrease the frequency of excisions and reduce the burden of disease for the patient3,4; however, there have been concerns that cidofovir may produce adverse effects, including increased risk of malignant transformation.5 Although several studies have found no increased risk of cancer in patients with RRP who are treated with cidofovir,6-11 the safety profile of intralesional cidofovir injection in patients with RRP is not fully understood. Understanding the safety of intralesional cidofovir is essential for otolaryngologists treating patients with RRP with a high burden of disease who may be seeking adjuvant therapies. This study aims to provide further data on the safety of intralesional adjuvant cidofovir to inform physicians in their decision to offer this treatment to patients.

23 February 2016 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
RKRobbi A. Kupfer
Robbi A. Kupfer
ETEmel Çadalli Tatar
Emel Çadalli Tatar
JBJonnae O. Barry
Jonnae O. Barry
CAClint T. Allen
Clint T. Allen
AMAlbert L. Merati
Albert L. Merati

1 August 2023 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
WBWilliam J Benjamin
William J Benjamin
NLNicholas R. Lenze
Nicholas R. Lenze
LBLauren A. Bohm
Lauren A. Bohm
MTMarc C. Thorne
Marc C. Thorne
RKRobbi A. Kupfer
Robbi A. Kupfer
RAReeni Abraham
Reeni Abraham

23 November 2011 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
RKRobbi A. Kupfer
Robbi A. Kupfer
RHRebecca C. Hoesli
Rebecca C. Hoesli
GGGlenn E. Green
Glenn E. Green
MTMarc C. Thorne
Marc C. Thorne

17 November 2023 in Academic Medicine
Verified
Journal Article
Closed access
WBWilliam J Benjamin
William J Benjamin
NLNicholas R. Lenze
Nicholas R. Lenze
LBLauren A Bohm
Lauren A Bohm
MTMarc C. Thorne
Marc C. Thorne
RAReeni Abraham
Reeni Abraham
RKRobbi A Kupfer
Robbi A Kupfer
Purpose To assess the impact of applicant and residency program characteristics on preference signaling outcomes in the Match during the first 2 years of implementation across 6 specialties. Method Data were obtained from the Texas Seeking Transparency in Application to Residency survey for applicants applying into otolaryngology during the 2020–2021 and 2021–2022 application cycles and into dermatology, internal medicine (categorical and preliminary year), general surgery, and urology during the 2021–2022 application cycle. The primary outcome was signal yield, defined as the number of interviews at signaled programs divided by the total number of signals sent. Associations with applicant-reported characteristics and geographic connections to residency programs were assessed using Wilcoxon rank sum testing, Spearman’s rank correlation testing, and ordinary least squares regression. Results 1,749 applicants with preference signaling data were included from internal medicine (n = 884), general surgery (n = 291), otolaryngology (n = 217), dermatology (n = 147), urology (n = 124), and internal medicine preliminary year (n = 86). On average 60.9% (standard deviation 32.3%) of signals resulted in an interview (signal yield). There was a stepwise increase in signal yield with the percentage of signals sent to programs with a geographic connection (57.3% for no signals vs. 68.9% for 5 signals, P < .01). Signal yield was positively associated with applicant characteristics, such as United States Medical Licensing Exam Step 1 and 2 scores, honors society membership, and number of publications (P < .01). Applicants reporting a lower class rank quartile were significantly more likely to have a higher percentage of their interviews come from signaled programs (P < .01). Conclusions Signal yield is significantly associated with geographic connections to residency programs and applicant competitiveness based on traditional metrics. These findings can inform applicants, programs, and specialties as preference signaling grows.